The Neuropathology of Progressive Multiple Sclerosis

N Evangelou, SML Paine, EC Tallantyre - Progressive multiple sclerosis, 2018 - Springer
sclerosis. What is often referred to as the normal appearing white matter in MRI studies, can
be demonstrated to possess features of disease … subtypes of multiple sclerosis. In particular, …

The neuropathology of progressive multiple sclerosis

L Bo, N Evangelou, E Tallantyre - Progressive Multiple Sclerosis, 2013 - Springer
… These pale areas are sometimes referred to as “shadow plaques.” At least some such
areas are likely to represent areas of remyelination [17]. Pathology studies indicate that …

Elucidating the functions of fibroblast growth factor 9 in multiple sclerosis

D McElroy - 2018 - theses.gla.ac.uk
… Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system.
In around 85% of cases, the disease progresses through two distinct stages: relapsing-remitting …

Chronic cortical pathology in multiple sclerosis: molecular studies on normal-appearing and demyelinated cortex and a novel animal model for chronic inflammatory …

LS Enz - 2020 - edoc.unibas.ch
… After the acute demyelinating phase, the lesions can develop into gliotic scar tissue (sclerosis),
and become chronic active or inactive lesions or they may remyelinate to form shadow

Biophysical methods for disease monitoring in dermatology

P Elsner, AO Barel, E Berardesca… - … and Applications in …, 1998 - books.google.com
… Using A mode ultrasound, Serup [14], showed that plaques of clinically advanced scleroderma
were thicker than plaques of slight scleroderma. The relative increase in thickness was …

Immune-mediated oligodendrocyte injury in multiple sclerosis: molecular mechanisms and therapeutic interventions

M Buntinx, P Stinissen, P Steels… - Critical Reviews™ in …, 2002 - dl.begellhouse.com
… ABSTRACT: In this review, new insights into the immunopathogenesis of multiple
sclerosis (MS) are discussed, with special focus on the potential mechanisms leading to …

Axonopathy and cytoskeletal disruption in degenerative diseases of the central nervous system

JC Vickers, AE King, A Woodhouse, MT Kirkcaldie… - Brain research …, 2009 - Elsevier
… conditions – amyotrophic lateral sclerosis, multiple sclerosis and Alzheimer's disease – with
emphasis on key cellular changes that may underlie early axonal dysfunction and pathology …

Super-resolving microscopy in neuroscience

C Werner, M Sauer, C Geis - Chemical Reviews, 2021 - ACS Publications
… disorders of the CNS can very roughly be subdivided into diseases that are mainly mediated
by deregulated cellular immune response, eg multiple sclerosis, by pathological humoral …

Ramifications of microglial activation on oligodendrocytes in in vitro models of multiple sclerosis

I Sevastou - 2010 - discovery.ucl.ac.uk
Oligodendrocytes are the principal target of immune attack in multiple sclerosis (… could
prevent microglial induced oligodendrocyte toxicity and could lead to strategies to slow disease

Cutaneous deposits

AM Molina-Ruiz, L Cerroni, H Kutzner… - The American Journal …, 2014 - journals.lww.com
… occur in systemic scleroderma. Calcinosis cutis in localized … Werner syndrome is an inherited
disorder that leads to … These processes usually occur on the aggregates of shadow cells. …